PODD — Insulet

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod s...

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Industry

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Sector

Healthcare

Exchange

NASD

First trade date

2007-05-15

The interactive platform loads with JavaScript. Research tools are for informational purposes.